Corrigendum to "botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction" [Neuroscience 159 (2009) 1422-1429] (DOI:10.1016/j.neuroscience.2009.01.066)

Y. Kitamura; Y. Matsuka; I. Spigelman; Yoshihito Ishihara; Y. Yamamoto; W. Sonoyama; H. Kamioka; T. Yamashiro; T. Kuboki; K. Oguma

doi:10.1016/j.neuroscience.2009.04.067

Corrigendum to "botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction" [Neuroscience 159 (2009) 1422-1429] (DOI:10.1016/j.neuroscience.2009.01.066)

Y. Kitamura, Y. Matsuka, I. Spigelman, Yoshihito Ishihara, Y. Yamamoto, W. Sonoyama, H. Kamioka, T. Yamashiro, T. Kuboki, K. Oguma

Research output: Contribution to journal › Comment/debate › peer-review

1 Citation (Scopus)

Original language	English
Pages (from-to)	950
Number of pages	1
Journal	Neuroscience
Volume	161
Issue number	3
DOIs	https://doi.org/10.1016/j.neuroscience.2009.04.067
Publication status	Published - Jul 7 2009

ASJC Scopus subject areas

Neuroscience(all)

Access to Document

10.1016/j.neuroscience.2009.04.067

Cite this

Kitamura, Y., Matsuka, Y., Spigelman, I., Ishihara, Y., Yamamoto, Y., Sonoyama, W., Kamioka, H., Yamashiro, T., Kuboki, T., & Oguma, K. (2009). Corrigendum to "botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction" [Neuroscience 159 (2009) 1422-1429] (DOI:10.1016/j.neuroscience.2009.01.066). Neuroscience, 161(3), 950. https://doi.org/10.1016/j.neuroscience.2009.04.067

Corrigendum to "botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction" [Neuroscience 159 (2009) 1422-1429] (DOI:10.1016/j.neuroscience.2009.01.066). / Kitamura, Y.; Matsuka, Y.; Spigelman, I. et al.
In: Neuroscience, Vol. 161, No. 3, 07.07.2009, p. 950.

Research output: Contribution to journal › Comment/debate › peer-review

Kitamura, Y, Matsuka, Y, Spigelman, I, Ishihara, Y, Yamamoto, Y, Sonoyama, W, Kamioka, H, Yamashiro, T, Kuboki, T & Oguma, K 2009, 'Corrigendum to "botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction" [Neuroscience 159 (2009) 1422-1429] (DOI:10.1016/j.neuroscience.2009.01.066)', Neuroscience, vol. 161, no. 3, pp. 950. https://doi.org/10.1016/j.neuroscience.2009.04.067

Kitamura Y, Matsuka Y, Spigelman I, Ishihara Y, Yamamoto Y, Sonoyama W et al. Corrigendum to "botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction" [Neuroscience 159 (2009) 1422-1429] (DOI:10.1016/j.neuroscience.2009.01.066). Neuroscience. 2009 Jul 7;161(3):950. doi: 10.1016/j.neuroscience.2009.04.067

Kitamura, Y. ; Matsuka, Y. ; Spigelman, I. et al. / Corrigendum to "botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction" [Neuroscience 159 (2009) 1422-1429] (DOI:10.1016/j.neuroscience.2009.01.066). In: Neuroscience. 2009 ; Vol. 161, No. 3. pp. 950.

@article{e45de0cbb79a4d26a68f58cf9ca8534e,

title = "Corrigendum to {"}botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction{"} [Neuroscience 159 (2009) 1422-1429] (DOI:10.1016/j.neuroscience.2009.01.066)",

author = "Y. Kitamura and Y. Matsuka and I. Spigelman and Yoshihito Ishihara and Y. Yamamoto and W. Sonoyama and H. Kamioka and T. Yamashiro and T. Kuboki and K. Oguma",

year = "2009",

month = jul,

day = "7",

doi = "10.1016/j.neuroscience.2009.04.067",

language = "English",

volume = "161",

pages = "950",

journal = "Neuroscience",

issn = "0306-4522",

publisher = "Elsevier Limited",

number = "3",

}

TY - JOUR

T1 - Corrigendum to "botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction" [Neuroscience 159 (2009) 1422-1429] (DOI:10.1016/j.neuroscience.2009.01.066)

AU - Kitamura, Y.

AU - Matsuka, Y.

AU - Spigelman, I.

AU - Ishihara, Yoshihito

AU - Yamamoto, Y.

AU - Sonoyama, W.

AU - Kamioka, H.

AU - Yamashiro, T.

AU - Kuboki, T.

AU - Oguma, K.

PY - 2009/7/7

Y1 - 2009/7/7

UR - http://www.scopus.com/inward/record.url?scp=65749097457&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=65749097457&partnerID=8YFLogxK

U2 - 10.1016/j.neuroscience.2009.04.067

DO - 10.1016/j.neuroscience.2009.04.067

M3 - Comment/debate

AN - SCOPUS:65749097457

SN - 0306-4522

VL - 161

SP - 950

JO - Neuroscience

JF - Neuroscience

IS - 3

ER -

Corrigendum to "botulinum toxin type A (150 kDa) decreases exaggerated neurotransmitter release from trigeminal ganglion neurons and relieves neuropathy behaviors induced by infraorbital nerve constriction" [Neuroscience 159 (2009) 1422-1429] (DOI:10.1016/j.neuroscience.2009.01.066)

ASJC Scopus subject areas

Access to Document

Other files and links

Cite this